HCP: I Don't Recommend This 4.7%-Yielding Healthcare REIT Anymore

Achilles Research
34.35K Followers

Summary

  • Healthcare REIT HCP does not make a compelling value proposition at today's price point.
  • The healthcare REIT is at the brink of being overbought and, probably, overvalued.
  • Investors may want to wait for drop before buying HCP for their income portfolios.
  • An investment an HCP yields 4.7 percent.

HCP, Inc. (HCP) is a promising income play for dividend investors in the healthcare REIT sector, but only at the right price. The healthcare real estate investment trust faces favorable long-term industry trends, has a strong balance sheet, and covers its dividend with AFFO. That said, though, the REIT's shares do not make an attractive value proposition for long-term dividend investors based on today's stretched valuation. In addition, HCP is at the brink of being overbought, potentially exposing investors to a correction over the short term. An investment in HCP yields 4.7 percent.

HCP - Portfolio Overview

HCP is a healthcare real estate investment trust with large investments in senior housing properties, medical office buildings, life science buildings, hospitals, and other healthcare-related facilities. Senior housing and medical office buildings account for the lion share (61 percent) of HCP's property investments.

Here's a breakdown by property type.

Source: HCP Investor Presentation

HCP benefits from an aging U.S. population and rising healthcare expenditures, especially as it relates to advanced age cohorts (80+). Strong projected growth in U.S. elderly demographics bodes well for HCP's senior housing part of the property portfolio going forward.

Source: HCP

At the same time, HCP benefits from increasing demand for outpatient care. Patients require easy, cost-effective and efficient visits to healthcare professionals, which is why outpatient revenues (which are directly related to medical office buildings) have steadily risen over the last couple of years.

Source: HCP

Balance Sheet Lends Some Downside Protection

HCP has an investment-grade rated balance sheet (BBB+ rating from Standard & Poor's, Baa2 rating from Moody's, and BBB rating from Fitch), which adds a layer of protection to the investment thesis in case the U.S. economy slides into a recession or the healthcare REIT industry heads for a downturn.

Source: HCP

Solid Distribution Coverage

HCP

This article was written by

34.35K Followers
I am a dividend investor and look for undervalued investments in the stock market. I identify misunderstood and undervalued equity investments and hold those securities until their price approximates my estimate of intrinsic value. I am a long-term investor only. I am building a $100,000 high-yield income portfolio. I am running this portfolio as an experiment to see if long-term sustainable income can be generated from a diversified pool of high-risk, high-yield securities. I am willing to accept high risk in order to meet my performance goals.

Analyst’s Disclosure:I am/we are long WELL, VTR. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About DOC Stock

SymbolLast Price% Chg
EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Compare to Peers

More on DOC

Related Stocks

SymbolLast Price% Chg
DOC
--